Université d'Helsinki (FINLANDE) Professeur Paul MICHIELSEN (1979) Université Catholique, Canada) Professeur James STEICHEN, 1989. ,
Université de Dundee (Royaume Uni) Professeur Duong Quang TRUNG (1997) Centre Universitaire de Formation et de Perfectionnement des, 1982. ,
Institute of Technology, Atlanta (USA) Professeur Mamish Nisbet MUNRO (1982) Massachusetts Institute of Technology, 2005. ,
Management of thrombotic thrombocytopenic purpura, Br J Haematol, vol.109, issue.3, pp.496-507, 2000. ,
Recent Advances in Thrombotic Thrombocytopenic Purpura, Hematology, vol.2004, issue.1, pp.407-430, 2004. ,
DOI : 10.1182/asheducation-2004.1.407
Thrombotic thrombocytopenic purpura, J Thromb Haemost, issue.38, pp.1663-75, 2005. ,
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura, N Engl J Med, issue.23, pp.307-1432, 1982. ,
Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura, Clin Lab, pp.47-54, 2001. ,
Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura, Expert Review of Cardiovascular Therapy, vol.113, issue.2, pp.243-55, 2003. ,
DOI : 10.1212/WNL.49.6.1552
Deficiency of ADAMTS-13 in thrombotic and thrombocytopenic purpura, Journal of Thrombosis and Haemostasis, vol.63, issue.9 ,
DOI : 10.1182/blood-2002-12-3796
Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience, Swiss Med Wkly, vol.133, pp.23-24, 2001. ,
Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura, Blood, vol.102, issue.9, pp.3241-3244, 2003. ,
DOI : 10.1182/blood-2003-05-1616
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias, British Journal of Haematology, vol.120, issue.4, pp.556-73, 2003. ,
DOI : 10.1172/JCI112394
Clinical practice Thrombotic thrombocytopenic purpura, N Engl J Med, issue.18, pp.354-1927, 2006. ,
Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome, Blood Transfus, vol.8, issue.3, pp.203-213, 2010. ,
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study, Annals of Hematology, vol.93, issue.6, pp.591-597, 2010. ,
DOI : 10.1007/s00277-009-0877-5
URL : https://hal.archives-ouvertes.fr/hal-00494349
Treatment of Thrombotic Thrombocytopenic Purpura With Vincristine, JAMA: The Journal of the American Medical Association, vol.247, issue.10, pp.1433-1439, 1982. ,
DOI : 10.1001/jama.1982.03320350037025
Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, Transfusion, vol.48, issue.2, pp.349-57, 1989. ,
Splenectomy for Thrombotic Thrombocytopenic Purpura, Annals of Surgery, vol.169, issue.4, pp.616-640, 1969. ,
DOI : 10.1097/00000658-196904000-00020
Frequently relapsing thrombotic thrombocytopenic purpura treated with cytotoxic immunosuppressive therapy, Haematologica, issue.8, pp.86-844, 2001. ,
Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura, Blood, vol.112, issue.1, pp.11-19, 2008. ,
DOI : 10.1182/blood-2008-02-078170
Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, The American Journal of Medicine, vol.107, issue.6, pp.573-582, 1999. ,
DOI : 10.1016/S0002-9343(99)00286-7
Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF, Thromb Haemost, vol.82, issue.5, pp.1382-1387, 1999. ,
The Multiple Organ Dysfunction Score (MODS) versus the Sequential Organ Failure Assessment (SOFA) score in outcome prediction, Intensive Care Med, issue.11, pp.28-1619, 2002. ,
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review, Transfusion, vol.139, issue.0, pp.382-92, 2008. ,
DOI : 10.1046/j.1526-0968.2002.00363.x
Central Nervous System Involvement in Thrombotic Thrombocytopenic Purpura, European Neurology, vol.40, issue.4, pp.220-224, 1998. ,
DOI : 10.1159/000007983
Cardiovascular Manifestations in Patients With Thrombotic Thrombocytopenic Purpura: A Single-center Experience, Clinical Cardiology, vol.150, issue.4, pp.213-219, 2010. ,
DOI : 10.7326/0003-4819-65-1-37
Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura, British Journal of Haematology, vol.138, issue.1, pp.66-74, 2006. ,
DOI : 10.1182/blood-2003-11-4035
URL : https://hal.archives-ouvertes.fr/hal-00453285
Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange*, Critical Care Medicine, vol.34, issue.8, pp.34-2127, 2006. ,
DOI : 10.1097/01.CCM.0000227659.14644.3E
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, vol.98, issue.6, pp.98-1765, 2001. ,
DOI : 10.1182/blood.V98.6.1765
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab, Transfusion, vol.12, issue.12, pp.50-2753, 2010. ,
DOI : 10.1024/0040-5930.65.12.710